Claudin-4 is frequently overexpressed in STAD, and membranous Claudin-4 expression correlates with better prognosis and reduced cancer cell migration and invasion, while also enhancing tight junction barrier function [17]. This evidence concerns the gene CLDN4 and gastric adenocarcinoma.